ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,166Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 197

$1M Total Retail Price of All Prescriptions

Rank: 12 out of 197

452 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 452 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

5% of this provider’s 452 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 4,690 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $130 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
RISPERIDONE 337 163 1 2
QUETIAPINE FUMARATE 277 111 2 3
NAMENDA 261 243 3 21
ZIPRASIDONE HCL 258 121 4 24
DIVALPROEX SODIUM ER 252 109 5 6
CITALOPRAM HBR 241 113 6 8
ESCITALOPRAM OXALATE 206 144 7 15
CYMBALTA 203 95 8 5
TRAZODONE HCL 191 72 9 1
MIRTAZAPINE 191 123 9 9
DONEPEZIL HCL 191 188 9 27
ABILIFY 179 121 12 10
BENZTROPINE MESYLATE 178 41 R 13 4
DIVALPROEX SODIUM 165 92 14 20
GABAPENTIN 162 84 15 31
EXELON 148 139 16 46
ZOLPIDEM TARTRATE 141 47 17 11
SERTRALINE HCL 138 58 18 7
HYDROCODONE-ACETAMINOPHEN 134 59 S3 19 41
BUPROPION HCL SR 126 22 20 32
SEROQUEL XR 124 34 21 22
LITHIUM CARBONATE 120 53 22 18
PRAZOSIN HCL 113 27 23 82
AMLODIPINE BESYLATE 112 75 24 47
RISPERDAL CONSTA 111 26 25 40
LEVOTHYROXINE SODIUM 111 68 25 42
SEROQUEL 109 43 27 17
PANTOPRAZOLE SODIUM 108 65 28 67
VENLAFAXINE HCL ER 102 51 29 14
OXCARBAZEPINE 98 26 30 30
OLANZAPINE 97 86 31 13
FUROSEMIDE 96 81 32 59
HALOPERIDOL 95 0 33 23
LAMOTRIGINE 93 0 34 16
METOPROLOL SUCCINATE 93 40 34 96
METHADONE HCL 93 44 S2 34 113
FLUOXETINE HCL 79 25 37 12
POTASSIUM CHLORIDE 73 57 38 84
SIMVASTATIN 69 51 39 50
METFORMIN HCL 67 28 40 53
LISINOPRIL 66 34 41 49
PAROXETINE HCL 65 43 42 25
LEXAPRO 63 39 43 51
HYDROXYZINE PAMOATE 62 0 R 44 29
ATENOLOL 61 26 45 95
TOPIRAMATE 59 11 46 36
AMITRIPTYLINE HCL 56 41 R 47 38
OMEPRAZOLE 54 35 48 35
GEODON 54 23 48 66
CLONIDINE HCL 52 23 50 52
NEXIUM 50 0 51 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.